Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2024 participants.
Also called NCT05749874
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,024 participants
- Registry
-
NCT05749874
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05749874. Randomized; quadruple masking; primary purpose treatment. Start 2023-10-31 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus
- Acronym
- ABCD
- Condition
- PreDiabetes
- Condition
- Abdominal Obesity
- Condition
- Hypertension
- Condition
- Dyslipidemias
- Condition
- Atherosclerotic Cardiovascular Disease
- Intervention (Drug)
- Berberine plus lifestyle intervention
- Intervention (Behavioral)
- Placebo plus lifestyle intervention
- Lead sponsor
- China National Center for Cardiovascular Diseases
Record details
- Record id
cardio:ct-nct05749874- Content hash
59b40460e5934b1801077d25d5b550768e9052b4ae1851f9b4c7d02c92b88ca3